2006-2007 Annual Report on the Attractiveness of Chinese Development Zones to th

2019-12-18 作者:澳门新普京游戏   |   浏览(145)

华夏报告网提示:Research 田野(field卡塔尔国s: biopharmaceuticals, development zonesManufacturers involved: Tiantan, Novo Nordisk, Tongrentang, Tianhe Pharmaceutical, Neptunus, Hayao, Xian-JanssenReport HighlightsIn 2005, sales of biopharmaceuticals enterprises

Research fields: biopharmaceuticals, development zonesManufacturers involved: Tiantan, Novo Nordisk, Tongrentang, Tianhe Pharmaceutical, Neptunus, Hayao, Xian-Janssen 澳门新普京游戏,Report Highlights In 2006, sales of biopharmaceuticals enterprises in Chinese development zones grew steadily by some 20%; yet profit evidently slowed down. Competition between development zones in the field of biopharmaceuticals shifts from policy environment to services. The establishment of technology platforms becomes an important means. Overview of development zones: Development zones offering generic technology platforms are more attractive to biopharmaceuticals enterprises. Moreover, development zones providing investment/financing and HR services also hold considerable competitiveness. Development zones offering these services become biopharmaceutical enterprises' preferred choiceIn the face of competition and changes and challenges in the market, CCID Consulting releases the 2006-2007 Annual Report on the Attractiveness of Chinese Development Zones to the Biopharmaceutical Industry. It will help vendors, investors, and industry chain grasp more accurately the model under which Chinese development zones develop the biopharmaceutical industry, and comb development zones' application value more deeply: Backed by full and accurate market description data, the report depicts the development of the development zones in 2006 from the dimensions of policy environment, basic services, platforms, investment environment, and development environment in the local areas, to discern development trends. After examining the competition performance of major development zones in 2006, it sums up their successes and failures from the dimension of service quality, meeting of requirements, and investment environment, and reviews the makings of leading players. It presents in-depth quantitative forecast of the market, assesses the measures taken by development zones to develop biopharmaceuticals, and ranks the development zones. Moreover, it examines impetuses and obstacles to development zones' attractiveness to the biopharmaceutical industry, and conducts multidimensional analysis of user demand.

中华报告网提醒:Research 田野同志s: biopharmaceuticals, development zonesManufacturers involved: Tiantan, Novo Nordisk, Tongrentang, Tianhe Pharmaceutical, Neptunus, Hayao, Xian-JanssenReport HighlightsIn 二〇〇六, sales of biopharmaceuticals enterprises

本文由新普京手机电子网站发布于澳门新普京游戏,转载请注明出处:2006-2007 Annual Report on the Attractiveness of Chinese Development Zones to th

关键词: